UNMA

UNMA Total Current Liabilities

$101.80MQuarterly · USD

Period ending:

UNMA FY Current LiabilitiesUSD
UNMA FY Current Liabilities1985-12-31: $0.001986-12-31: $0.001987-12-31: $0.001988-12-31: $0.001989-12-31: $0.001990-12-31: $0.001991-12-31: $0.001992-12-31: $0.001993-12-31: $0.001994-12-31: $0.001995-12-31: $0.001996-12-31: $25.96B1997-12-31: $29.67B1998-12-31: $30.63B1999-12-31: $32.00B2000-12-31: $32.87B2001-12-31: $34.20B2002-12-31: $733.80M2003-12-31: $201.90M2004-12-31: $123.00M2005-12-31: $481.80M2006-12-31: $701.30M2007-12-31: $698.10M2008-12-31: $654.40M2009-12-31: $589.50M2010-12-31: $661.80M2011-12-31: $745.50M2012-12-31: $882.50M2013-12-31: $490.30M2014-12-31: $548.50M2015-12-31: $736.20M2016-12-31: $363.70M2017-12-31: $573.00M2018-12-31: $363.30M2019-12-31: $790.20M2020-12-31: $374.70M2021-12-31: $370.10M2022-12-31: $367.50M2023-12-31: $399.40M2024-12-31: $676.00M2025-12-31: $0.00$34.20B$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

UNMA total current liabilities history

Liabilities due within one year. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Unum Group 6.250% Junior Subordinated Notes due 2058 Total Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Current Liabilities (USD)
0
676,000,000
399,400,000
367,500,000
370,100,000
374,700,000
790,200,000
363,300,000
573,000,000
363,700,000
736,200,000
548,500,000
490,300,000
882,500,000
745,500,000
661,800,000
589,500,000
654,400,000
698,100,000
701,300,000
481,800,000
123,000,000
201,900,000
733,800,000
34,199,000,000
32,872,000,000
31,998,000,000
30,627,000,000
29,670,000,000
25,962,000,000
0
0
0
0
0
0
0
0
0
0
0

Compare total current liabilities

All UNMA financial metrics · UNMA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.